Illumina 測(cè)序組合試劑盒 FC-140-1105

"Illumina/TruSight Rapid Capture (24 indexes, 96 samples, 8 enrichments)/FC-140-1105/1 Ea

" FC-140-1105 Illumina 產(chǎn)品編號(hào)： FC-140-1105美  元  價(jià)： $0.00會(huì)  員  價(jià)： 待定品       牌： Illumina產(chǎn)       地： 美國(guó)公       司： Illumina, Inc.產(chǎn)品分類： 其它>其它試劑>芯片公司分類： Clinical Research Products "Product Highlights:

Targeting genes previously linked to a predisposition towards cancer.

Illumina 測(cè)序組合試劑盒 FC-140-1105

Developed in collaboration with Professor Nazneen Rahman and team at the Institute of Cancer Research (ICR), London

Targets 94 genes and 284 SNPs associated with a predisposition towards cancer

TruSight Cancer includes genes associated with both common (e.g., breast, colorectal) and rare cancers. In addition, the set includes 284 SNPs found to correlate with cancer through genome-wide association studies (GWAS). Content selection was based on expert curation of the scientific literature and other high-quality resources.

The TruSight Cancer sequencing panel provides custom oligos targeting identified regions of interest. Sufficient product is supplied for four enrichment reactions. TruSight Cancer is compatIBLe with TruSight Rapid Capture.

TruSight Cancer Sample Datasets

6 human reference samples were prepared using the TruSight Cancer sequencing panel. These libraries were sequenced on the MiniSeq System using a high output kit at a 2 x 100 bp read length configuration with dual indexing. The total yield was 5.2 Gb with 95.8% of bases at or above Q30.

Browse the data in BaseSpace Sequence Hub:

View Run

View Project

* Note that access to this data requires a BaseSpace Sequence Hub login.

Register for BaseSpace Sequence Hub

Specifications:

Assay Time 1.5 days

Input Quantity 50 ng

System Compatibility MiSeq,NextSeq 550,MiSeqDx in Research Mode,MiniSeq,NextSeq 500

Specialized Sample Types Low Input

Technology Sequencing

Species Category Human

Variant Class Germline Variants

Cancer Type Pan-Cancer

Method Targeted DNA Sequencing"

Illumina公司，致力于新一代測(cè)序和芯片技術(shù)的生產(chǎn)與開發(fā)，提供產(chǎn)品與應(yīng)用資訊

Illumina公司創(chuàng)立于1998年4月，是遺傳變異和生物學(xué)功能分析領(lǐng)域的優(yōu)秀的產(chǎn)品、技術(shù)和服務(wù)供應(yīng)商。通過幫助客戶加快實(shí)現(xiàn)生物信息的采集、分析和應(yīng)用，來改善人類健康。

Sequencing Kits/ Microarray Kits/Informatics Products/ Clinical Research Products/In Vitro Diagnostic/ Products/Molecular Biology Reagents/ Accessory Products